We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | NASDAQ:CYCN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.135 | 4.79% | 2.955 | 1.14 | 3.20 | 3.13 | 2.70 | 2.81 | 1,680 | 21:05:29 |
Massachusetts
|
001-38787
|
83-1895370
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, no par value
|
CYCN
|
|
Item 3.02 |
Unregistered Sales of Equity Securities.
|
Item 5.03 |
Amendment to Articles of Incorporation or Bylaws.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
Articles of Amendment to the Restated Articles of Organization of the Company, as amended.
|
|
104
|
Cover Page Interactive Data File
|
Cyclerion Therapeutics, Inc.
|
|||
Dated: May 25, 2023
|
By:
|
/s/ Anjeza Gjino
|
|
Name:
|
Anjeza Gjino
|
||
Title:
|
Chief Financial Officer
|
1 Year Cyclerion Therapeutics Chart |
1 Month Cyclerion Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions